KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Charles River Laboratories International (CRL) Non Operating Income (2016 - 2025)

Historic Non Operating Income for Charles River Laboratories International (CRL) over the last 17 years, with Q3 2025 value amounting to -$22.6 million.

  • Charles River Laboratories International's Non Operating Income fell 97260.8% to -$22.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$57.4 million, marking a year-over-year decrease of 15036.78%. This contributed to the annual value of -$16.5 million for FY2024, which is 11729.17% down from last year.
  • As of Q3 2025, Charles River Laboratories International's Non Operating Income stood at -$22.6 million, which was down 97260.8% from $154000.0 recorded in Q2 2025.
  • In the past 5 years, Charles River Laboratories International's Non Operating Income registered a high of $115.5 million during Q4 2022, and its lowest value of -$39.8 million during Q2 2022.
  • Over the past 5 years, Charles River Laboratories International's median Non Operating Income value was -$3.3 million (recorded in 2023), while the average stood at $2.1 million.
  • In the last 5 years, Charles River Laboratories International's Non Operating Income skyrocketed by 547659.27% in 2022 and then tumbled by 97260.8% in 2025.
  • Over the past 5 years, Charles River Laboratories International's Non Operating Income (Quarter) stood at $2.1 million in 2021, then surged by 5476.59% to $115.5 million in 2022, then decreased by 6.76% to $107.7 million in 2023, then tumbled by 121.07% to -$22.7 million in 2024, then grew by 0.38% to -$22.6 million in 2025.
  • Its last three reported values are -$22.6 million in Q3 2025, $154000.0 for Q2 2025, and -$12.2 million during Q1 2025.